{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:57:01Z","timestamp":1790438221139,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T00:00:00Z","timestamp":1507852800000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007333","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009227","name":"Iowa State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-AG-024904"],"award-info":[{"award-number":["U01-AG-024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG047282"],"award-info":[{"award-number":["AG047282"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bbi.2016.07.148","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T18:47:02Z","timestamp":1468867622000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer\u2019s disease spectrum"],"prefix":"10.1016","volume":"58","author":[{"given":"Ashley","family":"Swanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Willette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2016.07.148_b0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2016.07.148_b0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11162-009-9121-3","article-title":"Multi-campus studies of college impact: which statistical method is appropriate?","volume":"50","author":"Astin","year":"2009","journal-title":"Res. High. Educ."},{"key":"10.1016\/j.bbi.2016.07.148_b0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0197-4580(00)00143-3","article-title":"Neuroinflammation and Alzheimer\u2019s disease: critical roles for cytokine\/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E","volume":"21","author":"Bales","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2016.07.148_b0020","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbi.2010.11.007","article-title":"Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling","volume":"25","author":"Ben Menachem-Zidon","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.07.148_b0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/brain\/awv017","article-title":"Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes","volume":"138","author":"Canto","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2016.07.148_b0030","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2016.07.148_b0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.bbi.2016.07.148_b0040","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","article-title":"Molecular mechanisms of neurodegeneration in Alzheimer\u2019s disease","author":"Crews","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbi.2016.07.148_b0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1172\/JCI77888","article-title":"Long-term potentiation decay and memory loss are mediated by AMPAR endocytosis","volume":"125","author":"Dong","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2016.07.148_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2015.04.014","article-title":"The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer\u2019s disease, mild cognitive impairment or Parkinson\u2019s disease","volume":"283","author":"Dursun","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2016.07.148_b0055","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1096\/fj.14-258350","article-title":"Reduced synaptic density and deficient locomotor response in neuronal activity-regulated pentraxin 2a mutant zebrafish","volume":"29","author":"Elbaz","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2016.07.148_b0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ncl.2006.03.010","article-title":"Age and neuroinflammation: a lifetime of psychoneuroimmune consequences","volume":"24","author":"Godbout","year":"2006","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.bbi.2016.07.148_b0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yfrne.2008.10.001","article-title":"Interleukin-1 (IL-1): a central regulator of stress responses","volume":"30","author":"Goshen","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.bbi.2016.07.148_b0070","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.07.148_b0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2174\/1871527311312050008","article-title":"Innate immunity in Alzheimer\u2019s disease: a complex affair","volume":"12","author":"Guillot-Sestier","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bbi.2016.07.148_b0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2016.07.148_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2010-1414","article-title":"Neuroinflammation in Alzheimer\u2019s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation","volume":"21","author":"Hensley","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2016.07.148_b0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/geno.1995.1134","article-title":"Human neuronal pentraxin II (NPTX2): conservation, genomic structure, and chromosomal localization","volume":"28","author":"Hsu","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.bbi.2016.07.148_b0095","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neuroimage.2012.10.086","article-title":"Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer\u2019s disease clinical trials","volume":"66","author":"Hua","year":"2013","journal-title":"NeuroImage"},{"key":"10.1016\/j.bbi.2016.07.148_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-015-0142-1","article-title":"Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer\u2019s disease in a memory clinic cohort","volume":"7","author":"Kester","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2016.07.148_b0105","doi-asserted-by":"crossref","first-page":"e68941","DOI":"10.1371\/journal.pone.0068941","article-title":"Evaluation of 41 candidate gene variants for obesity in the EPIC-potsdam cohort by multi-locus stepwise regression","volume":"8","author":"Kn\u00fcppel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2016.07.148_b0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/117727190700200023","article-title":"Human chitinases and chitinase-like proteins as indicators for inflammation and cancer","volume":"2","author":"Kzhyshkowska","year":"2007","journal-title":"Biomark Insights"},{"key":"10.1016\/j.bbi.2016.07.148_b0115","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/939426","article-title":"Biomarkers for microglial activation in Alzheimer\u2019s disease","author":"Lautner","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2016.07.148_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-5-37","article-title":"Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation","volume":"5","author":"Lee","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2016.07.148_b0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"Lee","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbi.2016.07.148_b0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ilar.52.3.321","article-title":"Mediating the effects of drug abuse: the role of NARP in synaptic plasticity","volume":"52","author":"Reti","year":"2011","journal-title":"ILAR J."},{"key":"10.1016\/j.bbi.2016.07.148_b0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-clinpsy-050212-185535","article-title":"Neuroimaging and other biomarkers for Alzheimer\u2019s disease: the changing landscape of early detection","volume":"9","author":"Risacher","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.bbi.2016.07.148_b0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.bbi.2016.07.148_b0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-4-48","article-title":"Alzheimer\u2019s disease: synaptic dysfunction and A\u03b2","volume":"4","author":"Shankar","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2016.07.148_b0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","article-title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","volume":"121","author":"Shaw","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2016.07.148_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneumeth.2013.08.024","article-title":"A comparison of random forest regression and multiple linear regression for prediction in neuroscience","volume":"220","author":"Smith","year":"2013","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbi.2016.07.148_b0160","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/prca.201400178","article-title":"Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) CSF","volume":"9","author":"Spellman","year":"2015","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.bbi.2016.07.148_b0165","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamaneurol.2015.1285","article-title":"Longitudinal cerebrospinal fluid biomarker changes in preclinical alzheimer disease during middle age","volume":"72","author":"Sutphen","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbi.2016.07.148_b0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/jnc.13072","article-title":"APOE-modulated Abeta-induced neuroinflammation in Alzheimer\u2019s disease: current landscape, novel data, and future perspective","volume":"133","author":"Tai","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2016.07.148_b0175","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1523\/JNEUROSCI.16-08-02463.1996","article-title":"Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity","volume":"16","author":"Tsui","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2016.07.148_b0180","doi-asserted-by":"crossref","first-page":"a006171","DOI":"10.1101\/cshperspect.a006171","article-title":"The neuropsychological profile of Alzheimer disease","volume":"2","author":"Weintraub","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.bbi.2016.07.148_b0185","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bbamem.2008.10.022","article-title":"The blood-brain barrier in brain homeostasis and neurological diseases","volume":"1788","author":"Weiss","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbi.2016.07.148_b0190","article-title":"Microglia in Alzheimer\u2019s disease: it\u2019s all about context","volume":"2012","author":"Weitz","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2016.07.148_b0195","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2337\/db14-1507","article-title":"Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease","volume":"64","author":"Willette","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbi.2016.07.148_b0200","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2016.07.148_b0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","article-title":"Immune modulation of learning, memory, neural plasticity and neurogenesis","volume":"25","author":"Yirmiya","year":"2011","journal-title":"Brain Behav. Immun."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116303427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116303427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:27:49Z","timestamp":1778761669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159116303427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":41,"alternative-id":["S0889159116303427"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2016.07.148","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer\u2019s disease spectrum","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2016.07.148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}